Versant Venture Capital VI is a Venture Capital Fund in California, that has raised $400.00 mm from 57 investors, for a fund started in Nov 2016. Data from SEC filing on 2 Jan 2017.
Company profile
Employees
Incorporated
Location
Fiscal year end
Industry
SEC CIK
Latest filings (excl ownership)
Latest ownership filings
SC 13D/A
LENZ Therapeutics, Inc.
25 Mar 24
4
LENZ Therapeutics, Inc.
25 Mar 24
SC 13D/A
Aligos Therapeutics, Inc.
8 Feb 24
SC 13D/A
Tempest Therapeutics, Inc.
8 Feb 24
SC 13G/A
Century Therapeutics, Inc.
8 Feb 24
SC 13D/A
Graphite Bio, Inc.
17 Nov 23
SC 13D/A
Tempest Therapeutics, Inc.
9 Nov 23
SC 13D/A
Passage BIO, Inc.
9 Nov 23
SC 13D/A
Monte Rosa Therapeutics, Inc.
9 Nov 23
SC 13D/A
Black Diamond Therapeutics, Inc.
9 Nov 23
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
21 Mar 24 | Versant Venture Capital VI | Common Stock | Other | Acquire J | Yes | No | 0 | 598,203 | 0.00 | 842,162 |
3 Jan 23 | Versant Venture Capital VI | Common Stock | Dispose U | Yes | No | 0 | 1,003,658 | 0.00 | 0 | |
3 Jan 23 | Versant Venture Capital VI | Common Stock | Dispose U | Yes | No | 0 | 2,465 | 0.00 | 0 | |
3 Jan 23 | Versant Venture Capital VI | Common Stock | Dispose U | Yes | No | 0 | 414,607 | 0.00 | 0 | |
3 Jan 23 | Versant Venture Capital VI | Common Stock | Dispose U | No | No | 0 | 2,236,888 | 0.00 | 0 |